Trial Profile
Treatment of Exudative Age-Related Macular Degeneration With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3: A Randomized Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jan 2020
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Omega-3-fatty-acid (Primary) ; Pranoprofen (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 30 Nov 2017 New trial record